Forbius, a clinical-stage company developing biologics for the treatment of cancer and fibrosis, announced that the firs...
Immutep Limited has announced that it has entered into a clinical trial collaboration agreement, a supply agreement and ...
Solasia Pharma K.K. has announced the initiation of Phase III clinical trial for PledOx in Japan. In November 2017, Sol...
Portola Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s ...
Apellis Pharmaceuticals Inc. has provided an update on the status of its Phase 3 program for APL-2 in patients with...
Apellis Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on the development of novel therap...
Bridge Biotherapeutics Inc, a clinical stage biotech company headquartered in Seongnam, South Korea has announced that t...
Clinical Stage company, Vedanta Biosciences developing a new category of therapies for immune-mediated diseases based on...
Merck and Pfizer Inc. has announced that data from a planned interim analysis of the Phase III JAVELIN Ovarian 100 study...
Singapore - Patrys Limited, a therapeutic antibody development company, is pleased to announce further pre-clinica...
Singapore – Both moderate-to-large weight gain and weight loss, defined as a change of 10% or more in weight, amon...
Eli Lilly and Company has announced that Taltz® (ixekizumab) met the primary and all major secondary endpo...
Asia-Pacific specialist CRO Novotech announced as part of its ongoing IT infrastructure investment program that it has i...
Innovent Biologics, Inc. and Incyte have entered into a strategic collaboration agreement for three clinical-stage produ...
Singapore – As a leading global city with a high population density, Singapore is vulnerable to the introduction o...
Tychan, a clinical-stage biotechnology company based in Singapore, announced today that its first-in-class candidate dru...
PAREXEL, a leading innovator of global biopharmaceutical services, has announced a new collaboration with Eli Lilly and ...
argenx, a clinical-stage biotechnology company has announced an exclusive, global collaboration and license agreement fo...
